The short answer
Appetite usually changes first, often within the first few weeks, and the weight follows more slowly. The first month is a starting dose, not a treatment dose: the labeled schedules step up every four weeks, and the drug level takes about four to five weeks to settle after each step. Expect a slow start, then a steady slope.
At GLP-1 SOS, “it has been three weeks and nothing is happening” is the message our support desk reads most often in a customer’s first month. Here is the timeline the labels and the trials actually describe.
The real timeline
Three phases, not one
1
Weeks 1 to 4: starting dose
Appetite shifts; the scale barely moves. This dose is testing your gut, not your weight.
2
Months 2 to 4: stepping up
Each step needs about five weeks to settle. A steady slope begins.
3
Month 4 onward: treatment dose
Most trial weight loss accrued here, across a year, then flattened.
What is actually happening
A GLP-1 medication works in two places. In the brain it acts on the regions that regulate appetite; the Wegovy prescribing information says its weight effect is likely mediated by affecting appetite. In the stomach it slows how fast food empties, so a small meal stays with you longer. Both effects begin with the first injection, so fullness arrives sooner and food takes up less of your thoughts in the first weeks, before the scale has moved much.
The first month is a titration dose. Wegovy starts at 0.25 mg once weekly for weeks 1 to 4, then 0.5 mg, 1 mg and 1.7 mg for four weeks each, with the maintenance dose of 1.7 mg or 2.4 mg from week 17. Zepbound starts at 2.5 mg for four weeks, a dose the label describes as for treatment initiation and not approved for maintenance, then 5 mg, with further 2.5 mg steps after at least four weeks on each. Those early doses exist to let the gut adapt, not to move weight.
Lab note
The first month tests your gut, not your weight.
Then there is the drug level itself. Semaglutide has a half-life of about one week, and its prescribing information states that steady-state exposure is reached after four to five weeks of once-weekly injections. Tirzepatide’s label puts steady state at four weeks. So each dose step is a five-week experiment, and for most of it the level is still climbing. Two shots at a new dose tell you almost nothing.
The trials set the realistic timeline. STEP 1 ran 68 weeks: 16 weeks of escalation, then 52 weeks at 2.4 mg, for an average loss of 14.9 percent of body weight against 2.4 percent on placebo. SURMOUNT-1 ran 72 weeks with up to 20 weeks of escalation, for average losses of 15 to 20.9 percent against 3.1 percent. Most of that weight came off across the year after escalation, on a steady slope that flattened toward the end.
What the trials measured
The numbers behind the timeline
68 weeks
STEP 1 trial length: 14.9% average loss on Wegovy 2.4 mg vs 2.4% placebo
72 weeks
SURMOUNT-1 trial length: 15% to 20.9% average loss on Zepbound vs 3.1%
4 to 5 weeks
for once-weekly semaglutide to reach a steady level after each dose step
Sources: Wegovy and Ozempic Prescribing Information, 2026; STEP 1, NEJM 2021; SURMOUNT-1, NEJM 2022.
What to do
- Judge appetite, not the scale, in month one. Notice fullness arriving sooner, fewer snacks, a smaller plate left unfinished, and write it down. That is the medication working at a dose meant to test your gut, not your weight.
- Weigh once a week, same morning. Daily weights swing with water, salt and stool on a slowed gut. One weekly number, before breakfast and after the bathroom, is the only line worth reading.
- Put your schedule on the calendar. Ask your prescriber which dose you are on, when the next step is due, and which dose counts as your maintenance dose. You cannot judge a dose you have not reached.
- Give every step five weeks. The drug level is still climbing for most of that time. Unless side effects are the problem, do not ask for a change before a step has had its five weeks.
- Eat like the appetite change is real. Protein first, small meals, stop at satisfied. The weight comes from the calories the appetite change removes; eating through the fullness signal removes nothing.
- Track what the scale cannot see. A waist measurement once a month, how one specific pair of pants fits, evening hunger on a 1 to 5 scale. These move before the weight does.
- Bring the log if a maintenance dose has done nothing. After a reasonable run at a maintenance dose with no change in appetite or weight, take the weekly weights and the appetite notes to your prescriber. Response varies between people, and a longer hold, the next step, or a different medication are all normal things to discuss.
From our support desk at GLP-1 SOS
If you wrote to us tonight saying it has been three weeks and nothing has changed, here is what we would say.
Three weeks in, most people are still on the starting dose, and the level from that dose has not even settled yet. So we would ask two things. Has anything changed about hunger: fullness arriving sooner, fewer snacks, food on your mind less? If yes, the medication is doing what the first month is for. And when is your next step due? The labels move every four weeks, and each step needs about five weeks before the level is steady. Weigh once a week, same morning, and write the appetite notes next to the number. If a full maintenance dose has run its course with no change at all, that log is what your prescriber needs to see. Nothing to buy for this one. Time is the ingredient.
We answer real questions from real people every day. Write to us if yours is not here.
Reading month one
What to expect, and what is not a fault
What to expect
- Fullness arriving sooner
- Fewer snacks without trying
- Food on your mind less
- Small weight change on a starting dose
- A steady slope after the steps
Not a sign it is failing
- A flat scale in weeks 1 to 4
- Daily weights that swing
- Two shots at a new dose, no change
- Slower loss than a friend on another dose
- Hunger returning the day before the shot
Judge a step after five weeks, not five days.
When to call your doctor
Call your prescriber the same day if:
- You are vomiting and cannot keep liquids down
- You have severe stomach pain that does not ease
- You feel faint when you stand
- You have not been able to eat or drink normally for more than a day
- Your urine is dark and scarce
- You take insulin or a sulfonylurea and feel shaky or confused
- Your mood drops in a way that worries you
A slow start is normal. Feeling sick every day is not.
From the people behind the Lab
You do not have to figure this out alone.
GLP-1 SOS is the daily companion made for life on a GLP-1. Plain answers like this one, a support team that replies to real questions from real people, and daily formulas like GLP-1 SOS Daily Gut Relief, designed around the side effects that come with the medication. The GLP-1 Lab is our free education arm: no login, no paywall, no hype. Side effects are part of the road. Suffering through them is not.
Questions people also ask
How fast does Ozempic or Wegovy suppress appetite?
For many people, within the first few weeks at the starting dose. The medication acts on appetite regions of the brain and slows the stomach from the first injection, so fullness arrives sooner and food noise quiets before the weight changes. Appetite is the earliest signal that the medication is working, and a flat scale in month one does not contradict it.
Why am I not losing weight on 0.25 mg of semaglutide or 2.5 mg of Zepbound?
Because those are starting doses. The Wegovy label schedules 0.25 mg for weeks 1 to 4 to reduce gut side effects before stepping up, and the Zepbound label says 2.5 mg is for treatment initiation and is not approved as a maintenance dose. Weight in the trials was measured after a full escalation and a year at the maintenance dose. Judge the dose you are on by appetite, and let the schedule do its job.
Does Zepbound work faster than Wegovy?
Neither label promises a faster start. Both use four-week steps, semaglutide reaches a steady level in four to five weeks per step and tirzepatide in four, and both are still starting doses in month one. SURMOUNT-1 ran 72 weeks and STEP 1 ran 68, and in both the weight came off over the whole year rather than the first month. The realistic difference in the early weeks is small; the schedule matters more than the molecule.
How much weight should I lose in the first month on a GLP-1?
No label sets a monthly target, and the first month is a starting dose in both schedules, so many people see little change on the scale while appetite is already shifting. The trial averages of 14.9 percent in STEP 1 and 15 to 20.9 percent in SURMOUNT-1 were measured at 68 and 72 weeks. A steady slope that begins once you reach a treatment dose is the realistic picture.
Sources (5)
- Wegovy (semaglutide) injection, Prescribing Information. Novo Nordisk / FDA, revised June 2026.
- Zepbound (tirzepatide) injection, Prescribing Information. Eli Lilly, revised August 2026.
- Ozempic (semaglutide) injection, Prescribing Information. Novo Nordisk, revised May 2026.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
Reviewed by the GLP-1 SOS editorial team · Education, not medical advice · Talk to your prescriber about your dose and your symptoms.
